Literature DB >> 22359705

Clinical characteristics of childhood guillain-barré syndrome.

Roshan Koul, Amna Al-Futaisi, Alexander Chacko, Mohammed Fazalullah, Susan Al Nabhani, Salah Al-Awaidy, Suleiman Al-Busaidy, Salim Al-Mahrooqi.   

Abstract

OBJECTIVES: To find the incidence, clinical pattern and outcome of Guillain-Barre syndrome in the Sultanate of Oman in children less than 15 years of age.
METHODS: All children under fifteen years with acute flaccid paralysis were admitted to identify the underlying cause. The diagnosis of Gullain Barre syndrome was made by clinical criteria, cerebrospinal fluid findings and nerve conduction studies. Intravenous immunoglobulins were given to all and two needed plasmapharesis.
RESULTS: Sixty-one children were diagnosed as Guillan-Barré syndrome and constituted 20% of cases of acute flaccid paralysis. Males 39 (63.9%) outnumbered females (36.1%).The annual incidence below 15 years was 0.45/100,000. Cranial nerves were involved in 31 (50.8%) children. Albumino-cytological dissociation in cerebrospinal fluid was seen in 42/45(93.3%) cases. Acute relapse was seen in six (9.8%) cases. Eleven children (18.3%) needed ventilation. Complete recovery was seen in 45 to 310 days (mean 69.1 days). Three children (4.9%) were left with minimal residual deficit. There was no mortality.
CONCLUSIONS: Guillain Barre syndrome is a serious disease, although recovery is the rule in children. The disease is associated with very low mortality and long term morbidity. Immunoglobulins have reduced the duration of hospital stay and the total time needed for recovery.

Entities:  

Keywords:  Children; Epidemiology; Guillain-Barré Syndrome; IVIG; Outcome; Plasmapharesis

Year:  2008        PMID: 22359705      PMCID: PMC3282330     

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  20 in total

Review 1.  Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  R A Hughes
Journal:  Ther Apher       Date:  1997-05

2.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Outcome of severe Guillain-Barré syndrome in children: comparison between untreated cases versus gamma-globulin therapy.

Authors:  Eli Shahar; Maxim Leiderman
Journal:  Clin Neuropharmacol       Date:  2003 Mar-Apr       Impact factor: 1.592

5.  Criteria for diagnosis of Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1978-06       Impact factor: 10.422

6.  Recurrent Guillain Barre' Syndrome: a clinical, electrophysiological and morphological study.

Authors:  A B Taly; S K Gupta; V Anisya; S K Shankar; S Rao; K B Das; D Nagaraja; H S Swamy
Journal:  J Assoc Physicians India       Date:  1995-04

7.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

8.  Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment.

Authors:  L H Castro; A H Ropper
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

9.  Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.

Authors:  H Rantala; J D Cherry; W D Shields; M Uhari
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

10.  Childhood Guillain-Barré syndrome in Paraguay, 1990 to 1991.

Authors:  D E Hart; L A Rojas; J A Rosário; H Recalde; G C Román
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

View more
  6 in total

1.  Guillain-barré syndrome: a clinical study of twenty children.

Authors:  Maneesh Kumar; Shrikiran Aroor; Suneel Mundkur; Sandeep Kumar
Journal:  J Clin Diagn Res       Date:  2015-01-01

2.  Ten years evaluation of epidemiology- and mortality-related factors in adults and children with Guillain-Barré syndrome in the north of Iran.

Authors:  Mozaffar Hosseininezhad; Seyed Sepehr Khatami; Sajjad Saadat; Mona Asghari; Hoora Ghovvati Choshal; Alireza Hooshmand Marvasti; Zahra Gholipour Soleimani
Journal:  Neurol Sci       Date:  2021-08-17       Impact factor: 3.830

3.  Prognosis of Guillain-Barré Syndrome in Children.

Authors:  Mohammad Reza Salehiomran; Ali Nikkhah; Mohadese Mahdavi
Journal:  Iran J Child Neurol       Date:  2016

4.  Guillain-Barré syndrome as a cause of acute flaccid paralysis in Iraqi children: a result of 15 years of nation-wide study.

Authors:  Jagar Jasem; Kawa Marof; Adnan Nawar; Yosra Khalaf; Sirwan Aswad; Faisal Hamdani; Monirul Islam; Andre Kalil
Journal:  BMC Neurol       Date:  2013-12-10       Impact factor: 2.474

5.  Using short-message-service notification as a method to improve acute flaccid paralysis surveillance in Papua New Guinea.

Authors:  Siddhartha Sankar Datta; Berry Ropa; Gerard Pai Sui; Ramzi Khattar; Ravi Shankar Santhana Gopala Krishnan; Hiromasa Okayasu
Journal:  BMC Public Health       Date:  2016-05-17       Impact factor: 3.295

6.  Clinical Features and Outcome of Guillain-Barré Syndrome in Children.

Authors:  Jafar Nasiri; Mohamadreza Ghazavi; Omid Yaghini; Mohamad Chaldavi
Journal:  Iran J Child Neurol       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.